Neurobiological Technologies Stock Alpha and Beta Analysis
| NTII Stock | USD 0.0001 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Neurobiological Technologies. It also helps investors analyze the systematic and unsystematic risks associated with investing in Neurobiological Technologies over a specified time horizon. Remember, high Neurobiological Technologies' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Neurobiological Technologies' market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Neurobiological | Build AI portfolio with Neurobiological Stock |
Neurobiological Technologies Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Neurobiological Technologies market risk premium is the additional return an investor will receive from holding Neurobiological Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Neurobiological Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Neurobiological Technologies' performance over market.| α | 0.00 | β | 0.00 |
Neurobiological Technologies expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Neurobiological Technologies' Buy-and-hold return. Our buy-and-hold chart shows how Neurobiological Technologies performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Neurobiological Technologies Market Price Analysis
Market price analysis indicators help investors to evaluate how Neurobiological Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurobiological Technologies shares will generate the highest return on investment. By understating and applying Neurobiological Technologies stock market price indicators, traders can identify Neurobiological Technologies position entry and exit signals to maximize returns.
Neurobiological Technologies Return and Market Media
The median price of Neurobiological Technologies for the period between Wed, Oct 1, 2025 and Tue, Dec 30, 2025 is 1.0E-4 with a coefficient of variation of 0.0. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Neurobiological Technologies Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Neurobiological or other stocks. Alpha measures the amount that position in Neurobiological Technologies has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neurobiological Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neurobiological Technologies' short interest history, or implied volatility extrapolated from Neurobiological Technologies options trading.
Build Portfolio with Neurobiological Technologies
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Neurobiological Technologies Backtesting, Neurobiological Technologies Valuation, Neurobiological Technologies Correlation, Neurobiological Technologies Hype Analysis, Neurobiological Technologies Volatility, Neurobiological Technologies History and analyze Neurobiological Technologies Performance. For more detail on how to invest in Neurobiological Stock please use our How to Invest in Neurobiological Technologies guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Neurobiological Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.